Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07466095) titled 'Observational Cross-sectional Study Aiming to Determine the Correlation Between Pulpal Status and IL-8 and Presepsin Levels in the Pulpal Blood' on March 8.
Study Type: Observational
Primary Sponsor: Cairo University
Condition:
Pulpitis - Irreversible
Pulpitis - Reversible
Intervention:
Diagnostic Test: IL-8 and Presepsin levels in the pulpal blood.
Recruitment Status: Not recruiting
Date of First Enrollment: November 1, 2026
Target Sample Size: 50
To know more, visit https://clinicaltrials.gov/study/NCT07466095
Published by HT Digital Content Services with permission from Health Daily Digest....